Arvinas Inc share price logo

Arvinas Inc

NASDAQ: ARVN

Small Cap

$9.73

+0.16

(+1.67%)

Live

as on

Arvinas Inc Stock Performance

as on May 14, 2026 at 4:13 am IST

  • Day's Low

    Day's High

    $9.57
    $10.06
    downward going graph

    1.64%

    Downside

    3.39%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.90
    $14.51
    downward going graph

    39.36%

    Downside

    49.13%

    Upside

    downward going graph

Arvinas Inc share price movements today

Previous Close
$9.57
Open
$9.81
Volume
398.2K
Day's Low - High
$9.57 - $10.06
52 Week Low - High
$5.90 - $14.51

Arvinas Inc Historical Returns

1 Month Return
-9.55 %
3 Month Return
-17.85 %
1 Year Return
+ 52.15 %
3 Year Return
-58.71 %
5 Year Return
-85.01 %

Arvinas Inc Stock Fundamentals & Key Indicators

Check Arvinas Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$617.4M

EPS (TTM)

-3.4924

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-247.1M

Revenue (TTM)

89.4M

Profit Margin

-247.54%

Return On Equity TTM

-42.28%

Arvinas Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arvinas Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Arvinas Inc image
Arvinas Inc
BUY$617.4M-85.01%NA-247.54%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Arvinas Inc Stock including INR - Dollar returns

The Arvinas Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arvinas Inc investment value today

Current value as on today

₹1,73,611

Returns

₹73,611

(+73.61%)

Returns from Arvinas Inc Stock

₹54,690 (+54.69%)

Dollar Impact

₹18,921 (+18.92%)

Analyst Recommendation on Arvinas Inc Stock

Based on 26 analysts

BUY

88.46%

Buy

11.54%

Hold

0.00%

Sell

Based on 26 analysts, 88.46% of analysts recommend a 'BUY' rating for Arvinas Inc. Average target price of $15.06

Arvinas Inc Share Price Target

Get share price movements and forecasts by analysts on Arvinas Inc.

What analysts predicted

35.39%UPSIDE

Target Price

$15.06

Current Price

$9.73

Analyzed by

26 Analysts

Target

$15.06

Arvinas Inc target price $15.06, a slight upside of 35.39% compared to current price of $9.73. According to 26 analysts rating.

Indian Investors' Interest in Arvinas Inc Stock

Search interest for Arvinas Inc Stock has increased by 205% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:205% versus previous 30 day period

Arvinas Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-43
25
76
102
59
188
22
41
9
15
Gross Profit
-44
23
74
102
59
188
22
41
8
-
Operating Income
-165
-83
-48
-60
-58
71
-71
-43
-71
-63
EBITDA
-163
-81
-46
-59
-56
72
-70
-34
-66
-63
Interest Expense
7
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
-
Income Before Tax
-153
-69
-35
-48
-45
83
-61
-34
-67
-57
Income Tax Expense
1
0
0
0
0
0
0
0
0
0
Net Income
-154
-69
-35
-49
-45
82
-61
-35
-67
-57
Net Profit Margin
359.16%
-274.31%
-46.01%
-48.05%
-76.18%
43.91%
-273.21%
-83.77%
-709.47%
-369.23%

Arvinas Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
14
42
21
46
131
78
263
262
Gross Profit
6
7
14
42
21
46
131
78
263
257
Operating Income
-16
-24
-43
-51
-124
-195
-263
-401
-250
-114
EBITDA
-13
-23
-43
-49
-120
-189
-255
-394
-243
-75
Interest Expense
0
0
0
0
0
0
12
-
-
-
Depreciation
-
0
0
2
4
6
8
7
6
5
Income Before Tax
-14
-24
-41
-70
-119
-191
-251
-366
-198
-80
Income Tax Expense
0
0
2
-8
-7
-7
20
0
0
0
Net Income
-14
-24
-41
-62
-111
-183
-271
-367
-198
-80
Net Profit Margin
-215.18%
-317.32%
-289.59%
-144.57%
-512.74%
-392.29%
-206.93%
-467.90%
-75.51%
-30.77%

Arvinas Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-69
-35
-49
-45
82
-61
-35
-67
-57
Operating Cash Flow
-97
50
-128
-84
-88
-95
-59
-30
-69
Investing Cash Flow
-127
13
50
98
69
128
63
145
13
Financing Cash Flow
1
3
2
0
0
0
-17
-74
0
Change in Cash
-223
66
-75
15
-19
33
-13
41
-55

Arvinas Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Operating Cash Flow
5
-16
-40
-89
559
-273
-347
-259
-273
Investing Cash Flow
20
-179
-93
164
-1,313
242
203
34
407
Financing Cash Flow
0
168
139
504
278
4
374
7
-91
Change in Cash
25
-27
6
579
-475
-26
230
-216
42

Global Institutional Holdings in Arvinas Inc

Funds
Holdings
Northern Trust Corp
0.85%
D. E. Shaw & Co LP
5.72%
Logos Global Management LP
8.72%
Point72 Asset Management, L.P.
3.59%
State Street Corp
2.86%
See all

Arvinas Inc News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 02:00 AM

    -

    Arvinas and Pfizer to out-license vepdegestrant commercialization rights; $100 million stock repurchase program authorized.

Insights on Arvinas Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ARVN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 9.5M → 15.6M (in $), with an average increase of 39.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -67.4M → -57.6M (in $), with an average increase of 17.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 90.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ARVN stock has moved down by -9.5%

About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
OrganisationArvinas Inc
Headquarters5 Science Park, New Haven, CT, United States, 06511
IndustryBiotechnology
CEODr. Randy Teel Ph.D.
E-voting on sharesClick here to vote

Key Management of Arvinas Inc

Name

Title

Mr. Alexander A. Santini

Chief Commercial Officer

Mr. Andrew R. Saik

CFO & Treasurer

Ms. Angela M. Cacace Ph.D.

Chief Scientific Officer

Mr. Jeff Boyle

Vice President of Investor Relations

Mr. Steve Weiss

Senior VP & Chief Human Resources Officer

Mr. Paul McInulty

Senior Vice President of Regulatory Affairs

Dr. Noah Berkowitz M.D., Ph.D.

Chief Medical Officer

Dr. Randy Teel Ph.D.

CEO, President & Director

Mr. David K. Loomis M.B.A.

VP & Chief Accounting Officer

Mr. Jared M. Freedberg J.D.

General Counsel & Corporate Secretary

FAQs

What is Arvinas Inc share price today?

Arvinas Inc share price today is $9.73 as on . Arvinas Inc share today touched a day high of $10.06 and a low of $9.57.

What is the 52 week high and 52 week low for Arvinas Inc share?

Arvinas Inc share touched a 52 week high of $14.51 on and a 52 week low of $5.9 on . Arvinas Inc stock price today i.e. is trending at $9.73,which is 32.94% down from its 52 week high and 64.92% up from its 52 week low.

What is Arvinas Inc's market capitalisation today?

Arvinas Inc market capitalisation is $0.00T as on .

How to invest in Arvinas Inc Stock (ARVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arvinas Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arvinas Inc Shares that will get you 0.1542 shares as per Arvinas Inc share price of $9.73 per share as on May 13, 2026 at 10:43 pm IST.

What is the minimum amount required to buy Arvinas Inc Stock (ARVN) from India?

Indian investors can start investing in Arvinas Inc (ARVN) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Arvinas Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arvinas Inc share’s latest price of $9.73 as on May 13, 2026 at 10:43 pm IST, you will get 1.0277 shares of Arvinas Inc. Learn more about fractional shares .

What are the returns that Arvinas Inc has given to Indian investors in the last 5 years?

Arvinas Inc stock has given -85.01% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?